Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protocadherin gamma-B2 (PCDHGB2) is a member of the protocadherin gamma gene cluster on chromosome 5, which contains genes likely involved in the formation and maintenance of specific neuronal cell-cell connections in the brain[1][5][8]. This protein is thought to act as a potential calcium-dependent cell-adhesion molecule, facilitating neural tissue architecture and synaptic specificity[2][5]. Its extracellular domain includes six cadherin ectodomains and a transmembrane region, while the constant cytoplasmic region is shared among the gamma cluster members[1][8]. PCDHGB2 is primarily expressed in the brain, where it plays a role in neuronal development, but currently has no established role as a therapeutic target or known drug interactions[1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protocadherin gamma-B2 (PCDHGB2).